Apply for Trial
News and Stories

SenseTime Healthcare’s AI-Powered Lung Cancer Screening Solution Fully Deployed Across Parkway Radiology’s network in Singapore

2025-10-10

 

SenseTime Healthcare and Parkway Radiology, a member of leading healthcare provider IHH Healthcare Singapore,  have launched a pioneering AI-powered lung cancer screening solution that has been fully deployed across  Parkway Radiology’s network in Singapore. This marks a significant step forward in integrating artificial intelligence into clinical workflows to enhance early detection and diagnosis, supporting the digital transformation of Singapore’s healthcare sector.

 

The partnership was recently highlighted for its cross-border innovation and clinical significance at the opening ceremony of the World Artificial Intelligence Conference on July 26, 2025. It was the only healthcare case study selected for the "China Intelligence, Benefiting the World (2025)" case study collection, which was unveiled at the event by Mr. Zheng Shanjie, Director of the National Development and Reform Commission, who personally recognized its significance.

 

Transforming Regional Healthcare through AI

 

SenseTime Healthcare’s proprietary AI-powered solution supports the early detection of lung cancer and improves clinical decision-making. Singapore is the first international market where SenseTime Healthcare’s AI-powered lung cancer screening technology has been fully integrated into Parkway Radiology’s core diagnostic workflows, a milestone that supports the company’s continued efforts to accelerate digital transformation across Southeast Asia.

 

The partnership demonstrates how industry collaboration within Singapore’s vibrant healthcare ecosystem can drive meaningful innovation, enabling advanced AI technologies to be translated into real-world clinical outcomes that benefit both patients and healthcare professionals.

 

Trusted and Certified for Clinical Excellence

 

In 2022, SenseTime Healthcare’s AI-assisted chest CT diagnostic device was registered as a medical device under Singapore’s Health Sciences Authority (HSA), representing the company’s robust technical foundation and commitment to international clinical and regulatory standards.

 

 Parkway Radiology made the decision to work  with SenseTime Healthcare as one of its AI partners following a stringent assessment of technical capabilities, product maturity, and alignment with long-term AI innovation goals. To support real-world application in Singapore, SenseTime worked closely with Parkway Radiology to localise and integrate the technology into hospital systems, including product customization, regulatory compliance, and algorithm refinement. This rigorous process ensured that the solution was catered to the clinical and operational needs of the local community.

 

The rollout of the SenseCare® AI-powered chest CT analysis system in 2024 across the Parkway Radiology network in Singapore reflects a shared commitment to harnessing AI for smarter, more efficient, and patient-centric care.

 

Intelligent Precision: AI as a Robust Clinical Assistant

SenseCare® offers significant clinical value in view of the rising incidence of lung cancer in Southeast Asia, where the need for the early detection and management of pulmonary nodules becomes ever more critical. The system serves as an “AI radiology assistant”, quickly and accurately detecting pulmonary nodules as small as a few millimeters in complex CT scans, providing risk assessments to support early diagnosis, improve efficiency, and reduce the risk of missed diagnoses.

 

For patient follow-ups, the system automatically compares imaging data across different time points, tracking changes in lesion size and density, and calculating growth rates. This enables clinicians to conduct more precise, data-driven evaluations and tailor personalized treatment plans that reduce unnecessary tests while ensuring timely intervention for high-risk patients.

图片3.png


 

Tangible Impact in Daily Clinical Practice

Since its deployment, the SenseCare® system has been seamlessly integrated into the daily workflow of IHH Healthcare Singapore’s radiology departments . More than 1800patients undergoing lung screening exams each month at IHH Healthcare Singapore hospitals, including Gleneagles Hospitals, Mount Elizabeth Hospital, Mount Elizabeth Novena Hospital and Parkway East Hospital,  now benefit from quicker and more accurate diagnoses.

 

By automating repetitive image comparisons and generating quantitative data, the system allows clinicians to focus on complex cases, reduce reporting turnaround times and deliver more proactive patient care. Ultimately, the aim is to leverage AI and uplift local communities through enhancing efficiency and quality in healthcare delivery.

 

A Milestone in Global Smart Healthcare

The successful collaboration between SenseTime Healthcare and Parkway Radiology  sets a new benchmark for AI deployment in real-world healthcare settings. It demonstrates how AI innovations can be effectively localised and embedded into healthcare systems, advancing clinical outcomes for our communities while empowering the broader digital transformation of the healthcare ecosystem globally.

 

Dr. Zhang Shaoting, Vice President of SenseTime and CEO of SenseTime Healthcare, said, “Our collaboration with Parkway Radiology marks a significant milestone in our journey to deliver accessible and effective AI-powered healthcare. The successful deployment of our AI-powered lung cancer screening solution within IHH Healthcare Singapore’s Parkway Radiology can be seamlessly localised and integrated into clinical workflows to support decision-making and enhance patient care. We look forward to deepening our partnership and further contributing to digital healthcare transformation efforts across Southeast Asia, expanding our service network to countries such as Indonesia, Malaysia and Thailand, supporting the broader adoption of AI-powered medical technologies globally.”